Introduction
If you were recently told you have fatty liver, you are not alone. Fatty liver disease—often called NAFLD in older literature and MASLD in newer guidelines—is now one of the most common liver conditions in the world. Recent global estimates suggest it affects about 30% of adults, and the burden is even higher in people with obesity, prediabetes, type 2 diabetes, and metabolic syndrome.
The good news is this: for many people, fatty liver can improve and sometimes reverse, especially before significant liver fibrosis develops. But reversal does not come from a miracle cleanse, a single capsule, or a weekend detox. It usually comes from steady changes in food, movement, sleep, insulin resistance, and body weight.
Ayurveda can contribute something valuable here. It does not describe “fatty liver” using the same modern labels, but it offers a useful framework around Agni (digestive and metabolic strength), Ama (poorly processed metabolic waste), Meda Dhatu (fat tissue/metabolic lipid balance), and Yakrit (liver). When interpreted carefully and used alongside evidence-based medicine, Ayurvedic nutrition, daily routine, yoga, and selected herbs may help support liver function, reduce inflammation, and improve metabolic health.
What Is Fatty Liver
Fatty liver means there is too much fat stored inside liver cells. In modern hepatology, the newer umbrella term is steatotic liver disease (SLD). When liver fat is linked to cardiometabolic risk factors such as obesity, diabetes, abnormal lipids, or hypertension, current guidelines call it MASLD. Many patients still search for and recognize the older term NAFLD, so both terms matter in practice.
A fatty liver is not always inflamed. Some people only have steatosis, also called simple fatty liver. Others develop steatohepatitis, where fat is joined by liver inflammation, cell injury, and a higher risk of liver fibrosis. Over time, that fibrosis can progress to cirrhosis, liver failure, or liver cancer in a smaller but important number of patients.
Why fatty liver matters
Fatty liver is not just a liver problem. It is closely tied to:
- Insulin resistance
- Central obesity
- Prediabetes and diabetes
- High triglycerides
- High blood pressure
- Chronic inflammation
- Oxidative stress
- Gut microbiome imbalance
That is why fatty liver treatment naturally starts with improving the whole metabolic environment, not just “cleansing” the liver.
Types of Fatty Liver
1. Simple fatty liver
Fat is present, but there is little or no active inflammation or cell injury.
2. Steatohepatitis
Fat plus inflammation and liver-cell damage. This stage carries a higher risk of fibrosis.
3. Fibrotic fatty liver
Scar tissue begins to form as the liver responds to ongoing injury.
4. Cirrhosis
Advanced scarring disrupts liver structure and function.
5. Alcohol-related vs non-alcohol-related
Doctors also separate liver fat related mainly to alcohol from liver fat related mainly to metabolic dysfunction. Even in “non-alcoholic” fatty liver, alcohol can still worsen the picture.
Symptoms to Watch For
Most people with fatty liver have no symptoms at all. It is often found by chance during blood tests or abdominal ultrasound. When symptoms do occur, they are usually vague.
Fatty liver symptoms table
| Stage | Common symptoms | What it may mean |
|---|---|---|
| Early/simple steatosis | Often none | Fat is present, but disease may still be mild |
| Mild active disease | Tiredness, low energy, bloating, poor appetite | Nonspecific symptoms; needs proper evaluation |
| Progressing disease | Right upper abdominal discomfort, persistent fatigue | Possible inflammation or liver enlargement |
| Advanced fibrosis/cirrhosis | Leg swelling, jaundice, itching, abdominal swelling, confusion | Urgent medical evaluation needed |
Important fact: Normal liver enzymes do not always mean a healthy liver, and abnormal enzymes do not tell you the stage by themselves.
Causes and Risk Factors
Fatty liver usually develops when the liver receives more fuel than it can safely process. That can happen through excess calories, sugar-heavy foods, visceral fat, poor insulin sensitivity, sleep disruption, low physical activity, and genetic susceptibility.
Risk factors table
| Risk factor | Why it matters |
|---|---|
| Obesity, especially belly fat | Raises liver fat and insulin resistance |
| Prediabetes/type 2 diabetes | Strongly linked to steatosis and fibrosis |
| High triglycerides / low HDL | Reflect metabolic dysfunction |
| Sedentary lifestyle | Reduces fat oxidation and insulin sensitivity |
| Sugary drinks / excess fructose | Promotes hepatic steatosis |
| Poor sleep / sleep apnea | Worsens inflammation and metabolic control |
| Rapid weight gain | Increases liver fat |
| Some medicines / supplements | May worsen liver injury or confuse the diagnosis |
| Alcohol use | Can accelerate liver damage |
| Family history / genetics | Alters personal risk |
People with type 2 diabetes deserve special attention. A large meta-analysis found that about 65% of people with type 2 diabetes also have NAFLD, and around 15% have advanced fibrosis.
Sugar, insulin resistance, and liver fat
Sugar-sweetened beverages deserve a direct mention. Repeated high intake can worsen insulin resistance and increase liver fat accumulation. This is one reason many liver guidelines advise reducing added sugar and especially fructose-rich drinks.
How Doctors Diagnose Fatty Liver
Modern diagnosis combines history, blood tests, imaging, and fibrosis risk assessment. In some cases, a liver biopsy is still needed.
Diagnosis table
| Test | What it helps assess | Notes |
|---|---|---|
| ALT, AST, platelets | Liver injury and fibrosis calculations | Helpful, but not enough alone |
| FIB-4 score | Risk of advanced fibrosis | Cheap, widely used first step |
| Ultrasound | Detects steatosis | Common, but less sensitive in mild disease |
| Transient elastography (FibroScan) | Liver stiffness and steatosis | Useful for fibrosis staging |
| MRI-PDFF / MRE | Accurate liver fat or fibrosis measurement | More advanced, often costlier |
| Liver biopsy | Confirms inflammation and fibrosis stage | Invasive; reserved for selected cases |
Current AASLD and EASL guidance supports a stepwise approach. A simple blood-based score such as FIB-4 is often used first. If the risk is higher, doctors may follow with elastography or other non-invasive tests to decide who needs closer follow-up or specialist care.
Can Fatty Liver Really Be Reversed
Short answer: often yes—but not at every stage
Simple fatty liver is the most reversible stage. Many people can lower liver fat significantly through weight loss, exercise, and better glucose control. Even steatohepatitis can improve. In some patients, fibrosis regression also happens, though it usually takes longer and is less predictable.
What level of change matters?
Guidelines and clinical studies are strikingly consistent:
- 3%–5% weight loss may improve steatosis
- 5%–7% weight loss can reduce liver fat further
- 7%–10% weight loss may support steatohepatitis improvement
- More than 10% weight loss is often needed to improve fibrosis
Evidence summary: Reversal is most realistic when liver fat is caught early, metabolic risk factors are treated, and changes are maintained for months—not days.
Timeline table: how long improvement may take
| Timeframe | What may improve |
|---|---|
| 2–6 weeks | Better energy, lower bloating, early glucose and triglyceride changes |
| 6–12 weeks | Improved liver enzymes in some patients |
| 3–6 months | Reduced liver fat on imaging if lifestyle changes are sustained |
| 6–12 months | Greater chance of steatohepatitis improvement |
| 12+ months | Fibrosis improvement is possible in selected patients |
This timeline varies by age, diabetes status, sleep, genetics, baseline fibrosis, and consistency.
What Modern Research Says About Reversing Fatty Liver
1. Weight loss remains the strongest treatment
Lifestyle therapy is still the foundation of care. In modern hepatology, there is broad agreement that body weight reduction—especially when it improves waist size, insulin sensitivity, and visceral fat—is the most reliable way to reverse fatty liver naturally.
2. Diet matters more than “detox”
A Mediterranean-style diet is one of the best-studied patterns for NAFLD. It emphasizes vegetables, legumes, nuts, whole grains, olive oil, fish, and lower intake of ultra-processed foods, red meat, and added sugars. Meta-analyses show it may improve hepatic steatosis, cardiometabolic markers, and insulin resistance.
3. Exercise works even without dramatic weight loss
Exercise improves liver fat even when the scale does not change much. A meta-analysis found exercise-based interventions reduced intrahepatic lipid and ALT, with better results when exercise lasted more than 3 months. Aerobic training and resistance training both help.
4. Coffee may help some patients
AASLD guidance notes that drinking 3 or more cups of coffee per day, when appropriate and not contraindicated, may be associated with lower risk of NAFLD and liver fibrosis. Coffee is not a treatment by itself, but it may be part of a healthy liver plan.
5. Sleep is not optional
Short sleep, insomnia, and obstructive sleep apnea are linked to higher NAFLD risk and worse progression. Poor sleep worsens hormones, appetite, insulin resistance, oxidative stress, and chronic inflammation. In practice, better sleep supports better liver outcomes.
6. The gut microbiome may matter
Newer research is exploring the gut-liver axis. When the gut barrier is impaired, bacterial products can reach the liver and drive inflammation. Healthy gut microbes also make SCFAs such as butyrate, which may support gut integrity, lower inflammation, and improve metabolism. This does not mean everyone needs probiotic supplements, but it does support fiber-rich eating patterns and less ultra-processed food.
Ayurveda’s Perspective on Fatty Liver
Ayurveda does not use the modern term NAFLD, but fatty liver can be interpreted through a pattern of Agnimandya (weak digestive-metabolic power), Ama accumulation, Meda imbalance, and Yakrit dysfunction.
Agni
In Ayurveda, Agni is more than digestion. It includes the body’s ability to transform food into usable tissue and energy. If Agni is weak, metabolism becomes sluggish. From a modern lens, this overlaps loosely with poor digestion, impaired metabolic flexibility, insulin resistance, and inefficient nutrient processing.
Ama
Ama refers to incompletely processed material that burdens normal physiology. It is not identical to any one modern biomarker, but it can be understood as a functional concept that overlaps with inflammatory burden, poor digestion, sluggish metabolism, and toxic load.
Meda Dhatu
Meda Dhatu broadly relates to fat tissue and lipid nourishment. When Meda is excessive or poorly regulated, Ayurveda links it to heaviness, lethargy, metabolic stagnation, and disorders of accumulation. That makes it a useful bridge concept when discussing obesity, dyslipidemia, and hepatic steatosis.
Yakrit and dosha involvement
The liver is understood as Yakrit. In a practical Ayurvedic interpretation of fatty liver:
- Kapha may dominate early accumulation and heaviness
- Pitta may contribute when inflammation and heat increase
- Vata may become more relevant in irregular progression, dryness, tissue depletion, or advanced disease
This does not mean every patient has the same dosha pattern. A skilled Ayurvedic assessment is individualized.
Clinical bridge: Ayurveda’s strength is not in replacing liver staging or elastography. Its strength is in helping patients build sustainable food habits, routine, mindful eating, movement, and digestive-metabolic balance that can support long-term change.
Ayurvedic Herbs With Scientific Evidence
Ayurvedic herbs are widely used for liver support, but the evidence is uneven. Some have small human studies. Others have only animal or lab data. A few may cause harm if used incorrectly or taken in contaminated products.
Herbs table
| Herb | Traditional role | Current evidence | Practical take |
|---|---|---|---|
| Curcumin / Turmeric (Haridra) | Supports inflammation balance and metabolism | Meta-analyses suggest it may improve ALT, AST, steatosis, fasting glucose, BMI, and cholesterol; evidence on fibrosis remains limited | Reasonable adjunct in selected patients; quality and formulation matter |
| Phyllanthus niruri (Bhumyamalaki) | Classical liver support herb | Mixed evidence; animal data are promising, but human evidence is limited and not consistently positive | May help, but should not be oversold |
| Picrorhiza kurroa (Kutki) | Traditionally used for liver and bile flow support | Stronger preclinical than human evidence | Interesting, but not yet a high-confidence clinical recommendation |
| Andrographis paniculata (Kalmegh) | Bitter herb for inflammation and liver support | Mostly preclinical NAFLD data | Evidence still early |
| Polyherbal formulas | Multi-target approach in Ayurveda | Some small RCTs show improvement with lifestyle support, but sample sizes and methods limit certainty | Consider only with qualified supervision |
| Tinospora cordifolia (Guduchi/Giloy) | Widely used in Ayurveda | Important safety caution: LiverTox lists it as a well-established cause of clinically apparent liver injury in reported cases | Avoid self-medication, especially in liver disease |
Curcumin has the most useful human data among commonly discussed Ayurvedic herbs. Updated meta-analyses suggest it may improve liver enzymes, hepatic steatosis, fasting glucose, BMI, and cholesterol, but the trials are heterogeneous and do not prove it reverses fibrosis in a robust way.
Some small clinical trials of Ayurvedic formulations—such as Sharapunkhadi combined with lifestyle changes—reported better short-term improvement than lifestyle measures alone. But these studies were small, sometimes open-label, and short in duration. That means the findings are promising, not definitive.
Safety note: “Natural” does not always mean safe. Tinospora/Guduchi/Giloy has been linked to clinically apparent liver injury, including severe cases. Any herbal plan for fatty liver should be supervised by a qualified physician and coordinated with your hepatologist if you have abnormal liver tests, fibrosis, autoimmune disease, or are taking regular medicines.
Modern Medicine vs Ayurveda
Comparison table: Modern Medicine vs Ayurveda
| Topic | Modern medicine | Ayurveda |
|---|---|---|
| Core view | Liver fat, inflammation, fibrosis, metabolic risk | Agni, Ama, Meda Dhatu, Yakrit, dosha balance |
| Diagnosis | Blood tests, FIB-4, ultrasound, elastography, MRI, biopsy | Constitutional assessment, digestion, bowel pattern, appetite, sleep, lifestyle pattern |
| Main goal | Reduce liver fat, inflammation, fibrosis risk, cardiometabolic risk | Improve metabolic balance, digestive strength, routine, tissue quality |
| Best-supported treatment | Weight loss, diet, exercise, diabetes and lipid control | Personalized diet, meal timing, daily routine, yoga, selected supervised herbs |
| Strength | Disease staging and risk prediction | Long-term adherence, behavior support, personalized lifestyle framing |
| Limitation | Often hard for patients to sustain lifestyle change alone | Evidence quality varies; cannot replace staging and medical evaluation |
| Ideal approach | Evidence-based medical management | Integrative support under qualified supervision |
The most sensible path for most patients is integrative, not oppositional. Use modern tests to know the stage. Use sustainable lifestyle change to improve the stage. Use Ayurveda where it can support adherence, appetite regulation, digestive comfort, sleep, and daily discipline—without making exaggerated cure claims.
A Practical 12-Week Fatty Liver Support Plan
1. Build your plate around whole foods
Best foods for fatty liver table
| Eat more often | Limit | Why |
|---|---|---|
| Leafy vegetables, gourds, cruciferous vegetables | Sugary drinks | Helps reduce calorie excess and improve insulin sensitivity |
| Lentils, beans, chickpeas | Refined sweets, bakery foods | Better fiber and satiety |
| Whole grains in controlled portions | Frequent fried foods | Supports glucose control |
| Nuts and seeds | Ultra-processed snacks | Reduces empty calories |
| Fish or lean protein | Processed meat | Better cardiometabolic profile |
| Curd/yogurt if tolerated | Heavy late-night meals | Helps appetite control |
| Olive oil or traditional moderate healthy fats | Repeated “cheat meals” | Reduces metabolic stress |
| Black coffee if suitable | Alcohol | Alcohol can worsen liver injury |
A useful Ayurvedic nutrition principle is to avoid overeating, irregular eating, constant snacking, and late heavy dinners. From a modern point of view, these habits worsen glycemic swings and promote hepatic steatosis.
2. Move every week, not just every weekend
Exercise table
| Type | Goal | How it helps |
|---|---|---|
| Brisk walking | 30–45 min, 5 days/week | Reduces liver fat, improves insulin sensitivity |
| Cycling/swimming | 150–300 min/week moderate activity | Good aerobic base |
| Resistance training | 2–3 sessions/week | Preserves muscle, improves glucose handling |
| Yoga + mobility | 15–20 min most days | Supports adherence, stress control, stiffness relief |
| Post-meal walking | 10–15 min after meals | Helps glucose regulation |
Regular physical activity should be treated like a prescription. Guidelines support 150–300 minutes/week of moderate aerobic exercise or 75–150 minutes/week of vigorous exercise, with resistance training added when possible.
3. Aim for steady weight loss, not crash dieting
Rapid weight loss can sometimes worsen liver inflammation, especially when nutrition is poor. Slow, sustainable loss is safer for most people.
4. Sleep 7–8 hours
Try to:
- Sleep and wake at a regular time
- Avoid heavy dinners late at night
- Reduce screen exposure before bed
- Screen for sleep apnea if you snore or feel exhausted during the day
5. Add simple yoga and breathing
Yoga is best used as a support tool, not a stand-alone cure. Gentle yoga, twisting postures within comfort, breathing exercises, and mindful walking may help stress regulation and adherence. This matters because stress and poor sleep often worsen food choices and insulin resistance.
6. Recheck progress
Useful follow-up markers may include:
- Weight and waist circumference
- ALT / AST
- Triglycerides
- HbA1c or fasting glucose
- FIB-4
- Repeat ultrasound or elastography, if advised
Liver Detox Myths You Should Ignore
Myth 1: A 3-day juice cleanse will remove liver fat
Fact: Liver fat improves through calorie control, weight loss, activity, and metabolic correction—not through extreme short-term cleanses.
Myth 2: Herbal means harmless
Fact: Some herbal and dietary supplements can injure the liver. Product quality, dose, contamination, and interactions matter.
Myth 3: If liver tests are normal, the liver is fine
Fact: Some people with meaningful fibrosis have near-normal enzymes. Risk scores and imaging may still be needed.
Myth 4: Only people who drink alcohol get fatty liver
Fact: Obesity, diabetes, insulin resistance, and metabolic syndrome are major causes even in non-drinkers.
Latest International Research and Future Directions
The field is moving fast. Several newer therapies are being studied not as replacements for lifestyle change, but as additions.
1. GLP-1 and dual incretin therapies
A phase 2 trial found semaglutide significantly increased NASH resolution, though fibrosis improvement was not clearly superior in that trial. The SYNERGY-NASH trial found tirzepatide improved MASH resolution and fibrosis endpoints more than placebo over 52 weeks. These results are important because they target both weight loss and metabolic dysfunction.
2. Resmetirom and the first approved MASH drug
In 2024, the FDA approved resmetirom (Rezdiffra) for adults with non-cirrhotic NASH/MASH with moderate to advanced fibrosis, to be used along with diet and exercise. That is a major milestone—but it does not replace lifestyle therapy.
3. Better non-invasive testing
FIB-4 and elastography are already routine, and 2024 reviews highlight newer composite scores and portable elastography tools that may improve case-finding and monitoring.
4. Microbiome-targeted approaches
Researchers are exploring whether probiotics, prebiotics, personalized fiber strategies, and gut-barrier support can improve fatty liver via the gut-liver axis, SCFA production, and lower endotoxin-driven inflammation. These ideas are promising but not yet standard of care.
Key Takeaways
- Yes, fatty liver can often be reversed, especially in early stages.
- The best evidence supports weight loss, exercise, Mediterranean-style eating, sleep improvement, and tight metabolic control.
- 3%–5% weight loss may lower liver fat. >10% is often needed to improve fibrosis.
- Ayurveda may help through diet, routine, digestive-metabolic support, yoga, and carefully chosen herbs.
- Ayurveda should complement, not replace, medical diagnosis and fibrosis assessment.
- Avoid “liver detox” marketing and unsupervised supplement use.
- If you have diabetes, obesity, or abnormal liver tests, ask for fibrosis risk assessment—often starting with FIB-4.
FAQ
1. Can fatty liver be reversed completely?
Often yes in early stages, especially simple steatosis. Reversal becomes harder once significant fibrosis or cirrhosis develops.
2. How long does it take to reverse fatty liver naturally?
Many people see liver enzyme improvement within weeks to months, but meaningful imaging or fibrosis improvement usually takes longer.
3. What is the best diet for fatty liver?
A Mediterranean-style, high-fiber, lower-sugar diet has the strongest evidence.
4. Is rice bad for fatty liver?
Not necessarily. Portion size, total calories, and what you eat with it matter more than one food alone.
5. Are eggs safe in fatty liver?
Usually yes, when part of a balanced diet and appropriate calorie intake.
6. Can thin people get fatty liver?
Yes. Lean NAFLD/MASLD exists, especially with insulin resistance, poor diet quality, genetics, or visceral fat.
7. Which exercise is best for fatty liver?
The best exercise is the one you can maintain. Brisk walking, cycling, and resistance training all help.
8. Can yoga help fatty liver?
Yoga may support stress control, sleep, movement, and adherence, but it should not be the only treatment.
9. Does coffee help fatty liver?
Coffee may be associated with lower fibrosis risk in some studies, but it is only one small part of the plan.
10. Do liver detox drinks work?
There is no strong evidence that detox drinks reverse fatty liver. Sustainable lifestyle change works better.
11. Can Ayurveda cure fatty liver?
Ayurveda should not be framed as a cure. It may help support metabolic health, digestion, routine, and symptom relief as part of an integrative plan.
12. Which Ayurvedic herb is best studied for fatty liver?
Curcumin has the strongest human evidence among commonly discussed Ayurvedic herbs, though the evidence is still not perfect.
13. Should I stop all alcohol if I have fatty liver?
It is wise to minimize or avoid alcohol, especially if you have inflammation or fibrosis.
14. What tests should I ask my doctor for?
Ask about liver enzymes, platelets, FIB-4, ultrasound, and whether elastography is needed.
15. When should I see a liver specialist?
If you have diabetes, obesity, abnormal liver tests, a high FIB-4, suspected fibrosis, or symptoms of advanced liver disease.
Medical Disclaimer
This article is for education only. It does not diagnose, treat, or replace personal medical advice. Fatty liver can progress silently. Please consult a qualified hepatologist, gastroenterologist, or physician, and if you want to use Ayurvedic medicines or herbs, consult a qualified Ayurveda doctor who can review your history, medicines, and liver reports. Never stop prescribed medicines or start supplements for liver disease without professional guidance.
References
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835. doi:10.1097/HEP.0000000000000323. Available from: https://pubmed.ncbi.nlm.nih.gov/36727674/
- Tacke F, Horn P, Wong VWS, Ratziu V, Bugianesi E, Francque S, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492-542. doi:10.1016/j.jhep.2024.04.031. Available from: https://pubmed.ncbi.nlm.nih.gov/38851997/
- American Gastroenterological Association. Lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease (NAFLD). Available from: https://gastro.org/clinical-guidance/lifestyle-modification-using-diet-and-exercise-to-achieve-weight-loss-in-the-management-of-nonalcoholic-fatty-liver-disease-nafld/
- World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- World Health Organization. Diabetes. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
- Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and its implications for liver transplantation. Hepatology. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/36626630/
- Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, Tan DJH, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72(11):2138-2148. doi:10.1136/gutjnl-2023-330110. Available from: https://pubmed.ncbi.nlm.nih.gov/37491159/
- National Institute of Diabetes and Digestive and Kidney Diseases. Definition & facts of NAFLD & NASH. Available from: https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts
- National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of NAFLD & NASH. Available from: https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/diagnosis
- Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8919523/
- Fernandez T, Viñuela M, Vidal C, Barrera F. Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. PLoS One. 2022;17(2):e0263931. doi:10.1371/journal.pone.0263931. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263931
- Nam H, Lee M, Kim J, et al. Effect of exercise-based interventions in nonalcoholic fatty liver disease: a systematic review with meta-analysis. Dig Liver Dis. 2023;55(9):1178-1186. doi:10.1016/j.dld.2022.12.013. Available from: https://pubmed.ncbi.nlm.nih.gov/36653265/
- Xue Y, et al. Effect of different exercise modalities on nonalcoholic fatty liver disease: a systematic review and network meta-analysis. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10940706/
- Kawaguchi T, Charlton M, et al. Effects of Mediterranean Diet in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Available from: https://pubmed.ncbi.nlm.nih.gov/34147036/
- Shi X, Xiong X, Li S, Zhao H, Song H, Wang J, et al. A systematic review and meta-analysis of randomized controlled trials: effects of Mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD. Food Funct. 2024;15(16):8248-8257. doi:10.1039/d4fo01461h. Available from: https://pubmed.ncbi.nlm.nih.gov/39076035/
- Hayat U, et al. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 studies. Available from: https://pubmed.ncbi.nlm.nih.gov/32920163/
- Ebadi M, et al. Effect of coffee consumption on non-alcoholic fatty liver disease incidence, prevalence and risk of significant liver fibrosis: systematic review with meta-analysis. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8471033/
- Yang J, et al. Short sleep duration and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Available from: https://pubmed.ncbi.nlm.nih.gov/36544011/
- Bu LF, et al. Non-alcoholic fatty liver disease and sleep disorders. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10989311/
- Bahitham W, Banoun Y, Aljahdali M, et al. “Trust your gut”: exploring the connection between gut microbiome dysbiosis and the advancement of MASLD/MASH. Front Nutr. 2025. Available from: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1637071/full
- Lukkunaprasit T, et al. An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10086025/
- Jalali M, Mahmoodi M, Mosallanezhad Z, et al. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Available from: https://pubmed.ncbi.nlm.nih.gov/31987259/
- Remya E, Goyal M, Varsakiya J. Efficacy of Sharapunkhadi powder and lifestyle modification in the management of nonalcoholic fatty liver disease: a randomized placebo-controlled clinical trial. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8614208/
- Singhal P, et al. Efficacy of herbomineral compounds and pathya in the management of NAFLD. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4535070/
- Hassan MRA, et al. Effects of one-year supplementation with Phyllanthus niruri in mild-to-moderate NAFLD. Available from: https://pubmed.ncbi.nlm.nih.gov/37313177/
- Raut A, et al. Picrorhiza kurroa: traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. Available from: https://pubmed.ncbi.nlm.nih.gov/35659739/
- Ran LS, et al. Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with NAFLD. Available from: https://pubmed.ncbi.nlm.nih.gov/36115008/
- National Institute of Diabetes and Digestive and Kidney Diseases. Tinospora. LiverTox. Available from: https://www.ncbi.nlm.nih.gov/books/NBK608429/
- Newsome PN, Buchholtz K, Cusi K, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384(12):1113-1124. doi:10.1056/NEJMoa2028395. Available from: https://pubmed.ncbi.nlm.nih.gov/33185364/
- Hartman ML, Lawitz EJ, Vuppalanchi R, et al. Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N Engl J Med. 2024;391(4):299-310. doi:10.1056/NEJMoa2401943. Available from: https://pubmed.ncbi.nlm.nih.gov/38856224/
- Harrison SA, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024. doi:10.1056/NEJMoa2309000. Available from: https://pubmed.ncbi.nlm.nih.gov/38324483/
- U.S. Food and Drug Administration. FDA approves first treatment for patients with liver scarring due to fatty liver disease. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease
- Lai JCT, et al. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11009030/
- Le P, et al. A systematic review and meta-analysis of paired biopsy or imaging studies of progression/regression in NAFLD. Clin Gastroenterol Hepatol. 2022. doi:10.1016/j.cgh.2022.07.033. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9898457/
- Agrawal AK, Yadav CR, Meena MS. Physiological aspects of Agni. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3221079/
- Manohar PR, et al. Critical review and validation of the concept of Āma. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3807959/
- Charaka Samhita Online. Meda dhatu. Available from: https://www.carakasamhitaonline.com/index.php/Meda_dhatu
- Charaka Samhita Online. Ama. Available from: https://www.carakasamhitaonline.com/index.php?title=Ama
- Ministry of AYUSH / PIB. Ministry of Ayush has taken multiple initiatives towards integration. Available from: https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2114965
- CCRAS. Clinical research. Available from: https://ccras.nic.in/services/clinical-research/
Read More
- Ayurveda and diabetes management
https://susrutaayurveda.com/madhumeha-diabetes-management-by-ayurveda/ - Ayurvedic diet for immunity and gut health
https://susrutaayurveda.com/ayurvedic-diet-for-immunity-wisdom-for-health/ - Adaptogens and stress in Ayurveda
https://susrutaayurveda.com/adaptogens-and-biohacking-with-ayurveda/ - Ayurvedic solutions for vitamin B12 deficiency
https://susrutaayurveda.com/ayurvedic-solutions-for-vitamin-b12-deficiency/ - Top Ayurvedic immunity boosters
https://susrutaayurveda.com/top-10-trending-ayurvedic-immunity-boosters/
No comment